Cargando…
Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray
BACKGROUND: Noninvasive prenatal testing (NIPT) allows for screening of fetal aneuploidy and copy number variants (CNVs) from cell-free DNA (cfDNA) in maternal plasma. Professional societies have not yet embraced NIPT for fetal CNVs, citing a need for additional performance data. A clinically availa...
Autores principales: | Soster, Erica, Tynan, John, Gibbons, Clare, Meschino, Wendy, Wardrop, Jenna, Almasri, Eyad, Schwartz, Stuart, McLennan, Graham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257834/ https://www.ncbi.nlm.nih.gov/pubmed/37301962 http://dx.doi.org/10.1186/s13039-023-00642-4 |
Ejemplares similares
-
Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants
por: Soster, Erica, et al.
Publicado: (2021) -
Positive cfDNA screening results for 22q11.2 deletion syndrome—Clinical and laboratory considerations
por: Soster, Erica, et al.
Publicado: (2023) -
Impact of mosaicism ratio on positive predictive value of cfDNA screening
por: Rafalko, Jill M., et al.
Publicado: (2020) -
A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory
por: Dyr, Brittany, et al.
Publicado: (2019) -
Prenatal cfDNA Screening for Emanuel Syndrome and Other Unbalanced Products of Conception in Carriers of the Recurrent Balanced Translocation t(11;22): One Laboratory’s Retrospective Experience
por: Soster, Erica, et al.
Publicado: (2023)